Electronic nicotine delivery systems: emerging science foundation for policy

• Published in: Tobacco control 2010-04, Vol.19 (2), p.89-90
• Main Authors: Henningfield, J E, Zaatari, G S
• Format: Article
• Language: English
• Subjects: Advertising restrictions; Air cleanliness; Bans; Carcinogens; Cigarette smoking; Cigarettes; Deposition; Drug Delivery Systems; Drug regulation; Editorial; Electronic cigarettes; Electronics; Emissions; Federal regulation; Food law; Humans; Industrial regulation; Internet; Laboratories; Lungs; Manufacturers; Marketing; Nicotine; Nicotine - administration & dosage; Nicotine - therapeutic use; Nicotinic Agonists - administration & dosage; Nicotinic Agonists - therapeutic use; Passive smoking; Poisoning; Pollutant emissions; Propylene glycols; Public health; Public Policy; Skin; Smoking - psychology; Smoking cessation; Smoking Cessation - methods; Studies; Tobacco; United States; United States Food and Drug Administration
• ISSN: 0964-4563; 1468-3318
• DOI: 10.1136/tc.2009.035279

[...]these short-term laboratory studies offer little basis for assessing the safety of ENDS as they would actually be used, which could involve hundreds of puffs per day for many years with puffing parameters varying widely. 21 Such promotion could undermine the benefits of clean air laws in motivating smoking cessation and aiding those who have quit to avoid relapse. [...]ENDS produce emissions that can be seen and smelled, and presumably contain nicotine, propylene glycol, and carcinogen-containing tobacco extracts and other substances; however, there has been no systematic study of emissions. 6 7 That is why WHO recommends that the use of ENDS in public settings should be subject to the same restrictions as those used to reduce second-hand tobacco smoke exposure under Article 8 of the Framework Convention on Tobacco Control. 22 ENDS raise many additional questions.